NASDAQ:CKPT - Checkpoint Therapeutics, Inc.
$2.75
 $-0.12
-4.18%
12:05PM EDT
2019-07-22
Checkpoint Therapeutics, Inc. is an immuno-oncology biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. The Company is engaged in developing a portfolio of human immuno-oncology targeted antibodies. The portfolio of antibodies that it licensed includes antibodies targeting programmed death-ligand 1 (PD-L1), glucocorticoid-induced Tumor necrosis factor receptor (TNFR) related protein (GITR) and carbonic anhydrase IX (CAIX). The Company focuses on developing the immuno-oncology and checkpoint inhibitor antibodies. The Company is developing three oral, small molecules, targeted anti-cancer agents, consisting of an inhibitor of epidermal growth factor receptor (EGFR) mutations, an inhibitor of the bromodomain and extra-terminal (BET) protein, BRD4, and an inhibitor of poly (ADP-ribose) polymerase (PARP). The Company is developing a clinical program for its PARP inhibitor. Additionally, it seeks to add additional immuno-oncology drugs, as well as other targeted therapies to create wholly-owned combinations that leverage the immune system and other complimentary mechanisms.The Company's pipeline of products includes Anti- carbonic anhydrase IX (CAIX), anti-GITR monoclonal antibody (mAb), anti-PD-L1 mAb, CK-101, CK-102 PARP and CK-103. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  CKPT     avg for
industry  
  avg for
sector  
42 stocks weight:  16. 68   217. 37   399. 45  
42 stocks rank:  3. 32 K 1. 27 K 716. 99  
# analyst opinions:  4. 00   13. 21   13. 71  
mean recommendation:  1. 50   2. 10   2. 04  

quick ratio:  1. 73   5. 49   1. 88  
current ratio:  1. 86   5. 87   2. 36  

target price low:  3. 82   83. 44   114. 90  
target price avg:  5. 17   106. 20   137. 90  
target price high:  2. 00   132. 30   158. 97  
1-yr high:  5. 50   111. 86   142. 57  
last close:  2. 87   86. 79   125. 44  
50-day avg:  3. 90   86. 68   122. 63  
200-day avg:  3. 16   89. 22   121. 38  
1-yr low:  1. 54   69. 78   100. 51  
volume:  24. 92 K 2. 62 M 3. 43 M
50-day avg volume:  154. 61 K 3. 20 M 4. 16 M
200-day avg volume:  85. 53 K 2. 99 M 4. 75 M

1-day return:  1. 41 % -1. 30 % -0. 99 %
this week return:  -1. 03 % 0. 45 % -0. 20 %
12-wk return:  -19. 61 % 0. 94 % 4. 84 %
52-wk return:  -4. 52 % -1. 30 % 10. 55 %

enterprise value (EV):  89. 65 M 45. 10 B 122. 38 B
market cap:  103. 79 M 38. 96 B 108. 40 B
enterprise/revenue (EV/R):  25. 50   57. 92   10. 21  
total revenue:  3. 52 M 9. 91 B 39. 98 B
total debt:  0. 00   10. 90 B 17. 48 B
net income (common):  -33. 49 M 2. 07 B 4. 05 B

shares outstanding:  29. 16 M 538. 09 M 1. 24 B
shares:  21. 26 M 548. 00 M 1. 22 B
shares short:  124. 05 K 10. 98 M 11. 87 M
shares short prior month:  131. 99 K 9. 32 M 12. 05 M
short ratio:  0. 60   5. 60   3. 34  
short % of float:  0. 55 % 6. 48 % 2. 64 %
total cash/share:  0. 39   10. 98   9. 19  
total cash:  14. 15 M 5. 93 B 6. 10 B
free cash flow:  -18. 42 M 2. 92 B 4. 55 B
operating cash flow:  -28. 80 M 3. 80 B 5. 78 B

book value:  0. 20   13. 35   27. 45  
price/book:  14. 57   4. 60   8. 78  
gross profits:  -30. 15 M 7. 44 B 36. 13 B
operating margins:  -964. 12 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  0. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -1. 10   2. 10   4. 23  
forward EPS:  -0. 78   3. 45   7. 10  
P/E:  -2. 61   1. 90   32. 10  
forward P/E:  -3. 68   6. 46   15. 47  
PE/G:  -1. 00   0. 70   -0. 54  
growth:  2. 60 % 265. 63 % 79. 11 %
earnings high:  -0. 16   0. 89   1. 68  
earnings avg:  -0. 17   0. 70   1. 57  
earnings low:  -0. 18   0. 46   1. 46  
revenue high:  1000. 00 K 2. 57 B 11. 07 B
revenue avg:  740. 00 K 2. 51 B 10. 91 B
revenue low:  300. 00 K 2. 45 B 10. 73 B
return on assets:  -81. 91 % -2. 34 % 5. 28 %
return on equity:  -186. 19 % -90. 08 % 133. 53 %
revenue growth:  2. 60 % 265. 25 % 73. 68 %
revenue/share:  0. 12   12. 72   60. 04  

beta (1yr vs S&P500):  1. 43   1. 27   0. 91  
sharpe (1yr):  0. 53   0. 16   0. 77  

held % insiders:  21. 74 % 6. 06 % 3. 29 %
held % institutions:  10. 34 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : CKPT
.    101.399 =       101.399 :: --> INITIAL WEIGHT <--
.    - 1.101 =       100.298 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.036 =       204.173 :: P/E factor
.      x 1.0 =       204.125 :: PE/G factor
.    x 1.572 =       320.957 :: beta factor
.    x 0.829 =       265.994 :: sharpe factor
.    x 2.317 =       616.393 :: current ratio factor
.    x 1.472 =       907.588 :: quick ratio factor
.    x 1.711 =       1553.28 :: short ratio factor
.    x 1.039 =      1613.847 :: revenue growth factor
.     x 1.44 =      2324.422 :: EV/R factor
.    x 1.138 =      2645.826 :: price-to-book factor
.                               --> PERFORMANCE <--
.    x 2.121 =       5611.25 :: sector+industry 1-year gains factor
.    x 1.009 =      5664.153 :: industry 12-weeks return factor
.    x 1.308 =      7408.081 :: industry 2-weeks return factor
.    x 1.235 =      9147.196 :: 50-day avg > 200-day avg
.    x 0.958 =      8764.934 :: "drift" penalty 1 days ago
.    x 0.997 =      8734.621 :: "drift" penalty 2 days ago
.    x 0.994 =      8680.282 :: "drift" penalty 3 days ago
.    x 0.959 =      8326.866 :: "drift" penalty 4 days ago
.    / 2.183 =       3814.22 :: overall "drift" factor
.    x 0.814 =      3103.806 :: largest single-day jump factor
.     x 0.07 =       216.898 :: low price factor
.    x 1.446 =       313.653 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.608 =       190.826 :: forward EPS factor
.    x 0.858 =       163.672 :: forward P/E factor
.    x 1.185 =       193.904 :: industry recommendation factor
.    x 2.642 =       512.216 :: company recommendation factor
.    x 1.003 =       513.632 :: factor historical industry gain for week 29
.   x 10.521 =      5404.146 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         8.574 :: reduced for readability
.    + 8.102 =        16.676 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     16.676 :: FINAL WEIGHT for NASDAQ:CKPT


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org